Cargando…

The challenge of PRRS immunology

Porcine reproductive and respiratory syndrome (PRRS) is one of the most challenging subjects of research in veterinary viral immunology, and the immune response against PRRS virus (PRRSV) still is poorly understood. Infected pigs develop a strong and rapid humoral response but these initial antibodi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mateu, E., Diaz, I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110845/
https://www.ncbi.nlm.nih.gov/pubmed/17644436
http://dx.doi.org/10.1016/j.tvjl.2007.05.022
_version_ 1783513151219695616
author Mateu, E.
Diaz, I.
author_facet Mateu, E.
Diaz, I.
author_sort Mateu, E.
collection PubMed
description Porcine reproductive and respiratory syndrome (PRRS) is one of the most challenging subjects of research in veterinary viral immunology, and the immune response against PRRS virus (PRRSV) still is poorly understood. Infected pigs develop a strong and rapid humoral response but these initial antibodies do not confer protection and can even be harmful by mediating an antibody-dependent enhancement of disease. In contrast, development of neutralising antibodies (NAs) is delayed and generation of cell-mediated immune responses, such as PRRSV-specific interferon (IFN)-γ secreting cells, is initially erratic. In spite of this, induction of strong and rapid NAs and IFN-γ responses seem to be required for effective vaccination. PRRSV strongly modulates the host’s immune responses. The virus inhibits key cytokines, such as IFN-α, and may induce regulatory cytokines, such as interleukin (IL)-10. Development of NAs seems to be impaired by the existence of a decoy epitope close to the main neutralisation epitope in glycoprotein 5. This ability to modulate the host immune response probably varies among strains or isolates. The genetic diversity of the virus is very high and it has been shown that this diversity can have serious implications for the development of vaccines, since the immunity induced by one strain may be only partial against a different strain, even within the same genotype. With this panorama, the development of newer and universally efficacious PRRSV vaccines is challenging, but the present state of knowledge allows optimism if collaborative efforts are undertaken in the scientific community.
format Online
Article
Text
id pubmed-7110845
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71108452020-04-02 The challenge of PRRS immunology Mateu, E. Diaz, I. Vet J Article Porcine reproductive and respiratory syndrome (PRRS) is one of the most challenging subjects of research in veterinary viral immunology, and the immune response against PRRS virus (PRRSV) still is poorly understood. Infected pigs develop a strong and rapid humoral response but these initial antibodies do not confer protection and can even be harmful by mediating an antibody-dependent enhancement of disease. In contrast, development of neutralising antibodies (NAs) is delayed and generation of cell-mediated immune responses, such as PRRSV-specific interferon (IFN)-γ secreting cells, is initially erratic. In spite of this, induction of strong and rapid NAs and IFN-γ responses seem to be required for effective vaccination. PRRSV strongly modulates the host’s immune responses. The virus inhibits key cytokines, such as IFN-α, and may induce regulatory cytokines, such as interleukin (IL)-10. Development of NAs seems to be impaired by the existence of a decoy epitope close to the main neutralisation epitope in glycoprotein 5. This ability to modulate the host immune response probably varies among strains or isolates. The genetic diversity of the virus is very high and it has been shown that this diversity can have serious implications for the development of vaccines, since the immunity induced by one strain may be only partial against a different strain, even within the same genotype. With this panorama, the development of newer and universally efficacious PRRSV vaccines is challenging, but the present state of knowledge allows optimism if collaborative efforts are undertaken in the scientific community. Elsevier Ltd. 2008-09 2007-07-20 /pmc/articles/PMC7110845/ /pubmed/17644436 http://dx.doi.org/10.1016/j.tvjl.2007.05.022 Text en Copyright © 2007 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Mateu, E.
Diaz, I.
The challenge of PRRS immunology
title The challenge of PRRS immunology
title_full The challenge of PRRS immunology
title_fullStr The challenge of PRRS immunology
title_full_unstemmed The challenge of PRRS immunology
title_short The challenge of PRRS immunology
title_sort challenge of prrs immunology
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110845/
https://www.ncbi.nlm.nih.gov/pubmed/17644436
http://dx.doi.org/10.1016/j.tvjl.2007.05.022
work_keys_str_mv AT mateue thechallengeofprrsimmunology
AT diazi thechallengeofprrsimmunology
AT mateue challengeofprrsimmunology
AT diazi challengeofprrsimmunology